Another type, activated B cell-like (ABC) DLBCL expresses genes characteristic of activated blood B cells (expressing IRF4, FLIP BCL-2, etc) and is associated with a poor clinical outcome. This evidence concerns the gene IRF4 and diffuse large B-cell lymphoma.